Regencell Bioscience

(NASDAQ) RGC

Current Price$30.27

Market Cap$16.67B

Since IPO (2021)+12,103%

5 YearN/A

1 Year+4,874%

1 Month+28%

Regencell Bioscience Financials at a Glance

Market Cap

$16.67B

Revenue (TTM)

$0.00

Net Income (TTM)

$3.59M

EPS (TTM)

$-0.01

P/E Ratio

-4683.33

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$30.27

Volume

5,325

Open

$33.00

Price

$30.27

Volume

5,325

Open

$33.00

Previous Close

$30.27

Daily Range

$29.63 - $37.49

52-Week Range

$0.58 - $83.60

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$30.27

Volume

5,325

Open

$33.00

Previous Close

$30.27

Daily Range

$29.63 - $37.49

52-Week Range

$0.58 - $83.60

RGC News

23_07_04 A scale showing risk from low to high with the pointer on the dial on high _MF Dload

Here's Why I Wouldn't Touch Regencell Bioscience With a 10‑Foot Pole Right Now

Reuben Gregg BrewerMar 6, 2026

22_01_26 A person looking at a computer screen with a look of unpleasant surprise _GettyImages-1216968860

Don't Even Think About Buying Regencell Bioscience Stock Until You See This 1 Red Flag

Reuben Gregg BrewerMar 5, 2026

This Stock Soared 9,800% in 2025. Here's 1 Key Reason Why Investors Are Piling In (Spoiler: It's Regencell Bioscience Holdings (RGC) Stock)

Selena MaranjianNov 24, 2025

Paper Certificate Shares Invest Stock Split Market Reverse Getty

Prediction: Wall Street's Latest Stock-Split Stock -- Up 60,120% Year-to-Date -- Is Going to Implode... It's Just a Matter of Time

Sean WilliamsJun 20, 2025

RGC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Regencell Bioscience

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Yat-Gai Au

Website

www.regencellbioscience.com

Headquarters

Causeway Bay, KY1-1107, HK

RGC Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-55%

Return on Capital

-74%

Return on Assets

-62%

Earnings Yield

-0.02%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$16.67B

Shares Outstanding

494.49M

Volume

5.33K

Short Interest

0.00%

Avg. Volume

422.28K

Financials (TTM)

Gross Profit

$392.74K

Operating Income

$3.77M

EBITDA

$3.19M

Operating Cash Flow

$3.11M

Capital Expenditure

$152.69K

Free Cash Flow

$3.27M

Cash & ST Invst.

$4.90M

Total Debt

$544.41K

Regencell Bioscience Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

$16.67B

N/A

Market Cap/Employee

$1.39B

N/A

Employees

N/A

Net Income

$1.73M

+34.6%

EBITDA

$1.73M

+48.5%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$4.35M

-60.8%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

+100.0%

Long Term Debt

$231.63K

+811.7%

Short Term Debt

$312.78K

-28.6%

Return on Assets

-62.27%

N/A

Return on Invested Capital

-74.04%

N/A

Free Cash Flow

$0.00

+100.0%

Operating Cash Flow

$0.00

+100.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MASIMasimo Corporation

MASIMasimo Corporation$178.59+0.33%

AXSMAxsome Therapeutics, Inc.

AXSMAxsome Therapeutics, Inc.$168.50-1.91%

CYTKCytokinetics, Incorporated

CYTKCytokinetics, Incorporated$66.73+0.18%

ATRAptarGroup, Inc.

ATRAptarGroup, Inc.$126.01-0.58%

ABVXAbivax S.A.

ABVXAbivax S.A.$118.37+2.96%

NUVLNuvalent, Inc.

NUVLNuvalent, Inc.$105.43-0.20%

GRFSGrifols, S.A.

GRFSGrifols, S.A.$8.24-0.12%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SKYQSky Quarry

SKYQSky Quarry$5.10+1.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$11.37-0.11%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$43.33+0.00%

TSLATesla

TSLATesla$360.59-0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$7.31-0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$77.29-0.00%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$584.98+0.00%

Regencell Bioscience

Regencell Bioscience Financials at a Glance

RGC News

Here's Why I Wouldn't Touch Regencell Bioscience With a 10‑Foot Pole Right Now

Don't Even Think About Buying Regencell Bioscience Stock Until You See This 1 Red Flag

This Stock Soared 9,800% in 2025. Here's 1 Key Reason Why Investors Are Piling In (Spoiler: It's Regencell Bioscience Holdings (RGC) Stock)

Prediction: Wall Street's Latest Stock-Split Stock -- Up 60,120% Year-to-Date -- Is Going to Implode... It's Just a Matter of Time

RGC: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Regencell Bioscience

RGC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Regencell Bioscience Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RGC

What is the current price of Regencell Bioscience?

What is the 52-week range for Regencell Bioscience?

How much debt does Regencell Bioscience have?

How much cash does Regencell Bioscience have on hand?

What is Regencell Bioscience’s dividend yield?

Premium Investing Services